Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Condition: Asthma
Interventions: Drug: QAV680; Drug: QAV680 Placebo
Sponsor: Novartis Pharmaceuticals
Terminated – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Posted

October 5, 2010

in

Asthma Clinical Trials U.S.

by

lowes1

Tags:

Asthma, Efficacy, patients, Pharmacokinetics, Placebo, QAV680, safety, versus

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.